Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

ClinicalTrials.gov ID: NCT01469377

Public ClinicalTrials.gov record NCT01469377. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder

Study identification

NCT ID
NCT01469377
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
819 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Cariprazine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2011
Primary completion
Dec 11, 2013
Completion
Dec 11, 2013
Last update posted
Apr 30, 2018

2011 – 2013

United States locations

U.S. sites
39
U.S. states
16
U.S. cities
37
Facility City State ZIP Site status
Forest Investigative Site 077 Garden Grove California 92845
Forest Investigative Site 019 National City California 91950
Forest Investigative Site 039 Oceanside California 92056
Forest Investigative Site 015 Orange California 92868
Forest Investigative Site 050 Orange California 92868
Forest Investigative Site 008 Redlands California 92374
Forest Investigative Site 066 Sherman Oaks California 91403
Forest Investigative Site 063 Gainesville Florida 32607
Forest Investigative Site 029 Jacksonville Florida 32256
Forest Investigative Site 012 Kissimmee Florida 34741
Forest Investigative Site 023 Miami Florida 33183
Forest Investigative Site 026 Orlando Florida 32806
Forest Investigative Site 062 Atlanta Georgia 30328
Forest Investigative Site 065 Smyrna Georgia 30080
Forest Investigative Site 074 Prairie Village Kansas 66206
Forest Investigative Site 040 Flowood Mississippi 39232
Forest Investigative Site 068 Creve Coeur Missouri 63141
Forest Investigative Site 061 Cherry Hill New Jersey 08002
Forest Investigative Site 038 Marlton New Jersey 08053
Forest Investigative Site 030 Albuquerque New Mexico 87106
Forest Investigative Site 076 Brooklyn New York 11235
Forest Investigative Site 037 Mount Kisco New York 10549
Forest Investigative Site 067 New York New York 10021
Forest Investigative Site 049 New York New York 10168
Forest Investigative Site 047 Canton Ohio 44718
Forest Investigative Site 021 Dayton Ohio 45417
Forest Investigative Site 022 Portland Oregon 97210
Forest Investigative Site 027 Salem Oregon 97301
Forest Investigative Site 069 Bridgeville Pennsylvania 15017
Forest Investigative Site 025 Philadelphia Pennsylvania 19139
Forest Investigative Site 031 Reading Pennsylvania 19604
Forest Investigative Site 048 Memphis Tennessee 38119
Forest Investigative Site 024 Austin Texas 78731
Forest Investigative Site 020 Dallas Texas 75231
Forest Investigative Site 070 Houston Texas 77054
Forest Investigative Site 080 San Antonio Texas 78229
Forest Investigative Site 028 Salt Lake City Utah 84106
Forest Investigative Site 032 Bellevue Washington 98007
Forest Investigative Site 034 Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01469377, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01469377 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →